TGFB1 and Hepatic fibrosis: GLA can also reduce the levels of inflammatory factors that are closely related to the gut microbiota, such as TNF-α, TGF-β, and ROS, thereby reducing the extent of liver fibrosis and addressing the imbalance of intestinal flora caused by liver diseases (Qu et al., 2023).